|

Insulin aspart Clinical Trials

4 actively recruiting trials across 1 location

▼ -2 trials since August 2026

Pipeline

Early 1: 2

Top Sponsors

  • Anna Stanhewicz, PhD2
  • Defymed1
  • Beijing Hospital1

Indications

  • Diabetes4
  • Gestational Diabetes2
  • Type 2 Diabetic Patients1
  • T2DM (Type 2 Diabetes Mellitus)1
  • Vascular Endothelial Function1

Other2 trials

Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
N/A
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
N/A

Iowa City, Iowa2 trials

Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

University of Iowa

Early 1
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

University of Iowa

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.